P3 Health Partners (PIIIW) Gains from Sales and Divestitures (2019 - 2022)

P3 Health Partners has reported Gains from Sales and Divestitures for 4 years, with the latest figure at $5.0 million in Q4 2022.

• For the quarter ending Q4 2022, Gains from Sales and Divestitures changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2022 stood at $5.0 million (changed N/A YoY), and the FY2022 full-year result was $5.0 million, changed N/A from the prior year.
• Gains from Sales and Divestitures for Q4 2022 stood at $5.0 million, up from $5.0 million in the prior quarter.
• The five-year high for Gains from Sales and Divestitures was $5.0 million in Q4 2022, with the low at $443750.0 in Q4 2020.
• Historically, Gains from Sales and Divestitures has averaged $2.5 million across 4 years, with a median of $660417.0 in 2021.
• The largest YoY upside for Gains from Sales and Divestitures was 29.93% in 2020 against a maximum downside of 29.93% in 2020.
• P3 Health Partners' Gains from Sales and Divestitures stood at $633333.0 in 2019, then retreated by 29.93% to $443750.0 in 2020, then surged by 48.83% to $660417.0 in 2021, then soared by 662.85% to $5.0 million in 2022.
• The last three Gains from Sales and Divestitures figures came in at $5.0 million (Q4 2022), $5.0 million (Q3 2022), and $4.9 million (Q2 2022), per Business Quant data.